HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden Q3: Sales of recently launched Elizabeth Arden Mediterranean and of With Love...Hilary Duff and double- digit growth of Elizabeth Arden skin care and cosmetics drove revenue up 14.6% to $219.2 mil. in the third quarter (ended March 31), Arden reports May 3. Sales of prestige fragrances to mass retail customers also contributed appreciably to the company's performance; Arden's U.S. mass retail business rose 26%, "well ahead" of category growth, firm says. Growth in Asia Pacific and the travel retail markets helped push international sales up more than 10%. During the third quarter, Arden completed its integration of Sovereign Sales, acquired last year (1"The Rose Sheet" Aug. 21, 2006, In Brief). Firm anticipates that "a strong pipeline" of new mass fragrance brands for the U.S. market will drive 2007 sales up 15% to 18% over the prior year to $954.6 mil...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS014708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel